The Tall-Tale Heart
On this occasion, the TARGET-CTCA trial1, just published in the New England Journal […] EMCrit Project by Rory Spiegel.
Useful takeaways from this story.
On this occasion, the TARGET-CTCA trial1, just published in the New England Journal […] EMCrit Project by Rory Spiegel.
It seems like every few years, someone tests whether further risk stratification in patients following a negative workup for acute coronary syndrome (ACS) provides a clinically meaningful benefit, and the...
Building the complete brief
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
The useful part
On this occasion, the TARGET-CTCA trial1, just published in the New England Journal […] EMCrit Project by Rory Spiegel. It seems like every few years, someone tests whether further risk stratification in patients following a negative workup for acute coronary syndrome (ACS) provides a clinically meaningful benefit, and the answer has been remarkably consistent.
How it works
- It seems like every few years, someone tests whether further risk stratification in patients following a negative workup for acute coronary syndrome (ACS) provides a clinically meaningful benefit, and the...
Keep reading in the app
Open the app view to save this story, compare related coverage, and continue from the same source.